Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%)
< Home < Back

Natco Pharma informs about earnings call transcript

Date: 21-08-2024
Natco Pharma has enclosed copy of the transcript of the Company's earnings conference call for Q1 FY25 held on August 13, 2024. The transcript is also available in the website of the company, www.natcopharma.co.in.

The above information is a part of company’s filings submitted to BSE.